OraSure Technologies Inc
NASDAQ:OSUR

Watchlist Manager
OraSure Technologies Inc Logo
OraSure Technologies Inc
NASDAQ:OSUR
Watchlist
Price: 3.88 USD 0.78% Market Closed
Market Cap: 289.4m USD
Have any thoughts about
OraSure Technologies Inc?
Write Note

OraSure Technologies Inc
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

OraSure Technologies Inc
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
OraSure Technologies Inc
NASDAQ:OSUR
Current Portion of Long-Term Debt
$41k
CAGR 3-Years
-72%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Current Portion of Long-Term Debt
$5.4m
CAGR 3-Years
-60%
CAGR 5-Years
-37%
CAGR 10-Years
12%
ICU Medical Inc
NASDAQ:ICUI
Current Portion of Long-Term Debt
$52m
CAGR 3-Years
343%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Align Technology Inc
NASDAQ:ALGN
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Lantheus Holdings Inc
NASDAQ:LNTH
Current Portion of Long-Term Debt
$564.7m
CAGR 3-Years
279%
CAGR 5-Years
123%
CAGR 10-Years
N/A
Merit Medical Systems Inc
NASDAQ:MMSI
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

OraSure Technologies Inc
Glance View

Market Cap
289.4m USD
Industry
Health Care

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. The company is headquartered in Bethlehem, Pennsylvania and currently employs 785 full-time employees. The firm's products include molecular sampling kits for the genome and microbiome services and analytics, rapid diagnostics for infectious disease, and tests for substance abuse. OraSure’s segments include Diagnostics segment and Molecular Collection Systems segment. The Diagnostics business primarily consists of the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices. The Molecular Solutions business consists of the manufacture and sale of kits that are used to collect, stabilize, transport and store biological samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, infectious disease diagnostics, pharmacogenomics, personalized medicine, microbiome and animal genetics markets.

OSUR Intrinsic Value
4.07 USD
Undervaluation 5%
Intrinsic Value
Price

See Also

What is OraSure Technologies Inc's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
41k USD

Based on the financial report for Sep 30, 2024, OraSure Technologies Inc's Current Portion of Long-Term Debt amounts to 41k USD.

What is OraSure Technologies Inc's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
-37%

Over the last year, the Current Portion of Long-Term Debt growth was -96%. The average annual Current Portion of Long-Term Debt growth rates for OraSure Technologies Inc have been -72% over the past three years , -37% over the past five years .

Back to Top